US panel rejects routine use of BRCA cancer screening in women

BMJ 2013; 346 doi: http://dx.doi.org/10.1136/bmj.f2160 (Published 4 April 2013)
Cite this as: BMJ 2013;346:f2160

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Michael McCarthy
  1. 1Seattle

Women whose family history does not suggest that they have an increased risk of carrying harmful BRCA1 and BRCA2 mutations should not undergo routine BRCA testing, according to draft recommendations released on 2 April by the US Preventive Services Task Force (USPSTF).1

Women whose family history suggests that they carry the cancer susceptibility genes should be tested but only after expert genetic counseling, the USPSTF panel said.

About 12.3% of women will develop breast cancer in their lifetime, and 2.8% will die from the disease. Clinically …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL